We are happy to jointly lead Genalyte’s last financing with Verily (Alphabet subsidiary) with the participation of Redmile Group, Provenio Capital, HBM Healthcare Investments, Khosla Ventures, Samsara BioCapital, and The Invus Group.

Article by
Article Date
Category

Related posts

Browse all articles

We are Happy to Lead PrinterPrezz's Series A Financing

PrinterPrezz Inc combines additive manufacturing and nanotechnology with a foundry ecosystem to develop medical devices from concept and design through FDA approval and volume production.

We are Happy to Lead Filtricine's Seed Funding Round

Filtricine, Inc. is developing a proprietary targeted medical food technology to help cancer patients manage their diseases.